tirzepatide 2.5 injection Zepbound mg/0.5 mL (single-dose vial) Images How the weight loss drug

For individuals who have not achieved desired results through diet and exercise alone, tirzepatide weight loss treatment offers a new hope

According to Obesity Canada guidance: Adults (18+) are eligible for all GLP-1-based weight-loss medications Adolescents (12 years old) may be eligible for certain agents (e.g., liraglutide and semaglutide) depending on clinical context and approval status use in younger populations requires specialist involvement

But in the late 1990s and early 2000s, infomercials for a plethora of products began appearing on American television, sold by a man named Kevin Trudeau

10.1126/science.1523409 Science

S.BartelsmanJ